Retraction Watch

Weekend reads: A paper written by ChatGPT goes viral; the Gino misconduct investigation report; superconductivity scandal

Would you consider a donation to support Weekend Reads, and our daily work?

The week at Retraction Watch featured:

Misspelled cell lines take on new lives — and why that’s bad for the scientific literature
Journal blacklists doctor in Pakistan ‘out of an abundance of caution’
Up to one in seven submissions to hundreds of Wiley journals flagged by new paper mill tool
Rejected paper pops up elsewhere after one journal suspected manipulation

Our list of retracted or withdrawn COVID-19 papers is up past 400. There are more than 47,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains more than 250 titles. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers? What about The Retraction Watch Mass Resignations List?

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Rejected paper pops up elsewhere after one journal suspected manipulation

In the autumn of 2022, a researcher in Turkey was reviewing a paper for a cardiology journal when an image of a Western blot caught her eye: A hardly visible pair of “unusual” lighter pixels seemed out of place. Magnification only bolstered her suspicion that something was off.

“This image made me think that the bands were cut one by one and pasted on a membrane background,” Şenay Akin, of Hacettepe University in Ankara, wrote in her comments to the editor of Cardiovascular Drugs and Therapy, a Springer Nature journal. “If this is the case, it indicates a manipulation [of] the results of this study.”

The editor, Yochai Birnbaum of Baylor College of Medicine in Houston, Texas, made a note to check the figure, adding below Akin’s comments in the editorial-management system: “I agree with the reviewer. It could be that the I/R band was manipulated.”

Up to one in seven submissions to hundreds of Wiley journals flagged by new paper mill tool

Wiley, whose Hindawi subsidiary has attracted thousands of paper mill papers that later needed to be retracted, has seen widespread paper mill activity among hundreds of its journals, it announced yesterday.

More than 270 of its titles rejected anywhere from 600 to 1,000 papers per month before peer review once they implemented a pilot of what the publisher calls its Papermill Detection service. That service flagged 10-13% of all of the 10,000 manuscripts submitted to those journals per month, Wiley told Retraction Watch.

Wiley said the service includes “six distinct tools,” including looking for similarities with known paper mill papers, searching for “tortured phrases” and other problematic passages, flagging “irregular publishing patterns by paper authors,” verifying researcher identity, detecting hallmarks of generative AI, and analyzing the relevance of a given manuscript to the journal.

Journal blacklists doctor in Pakistan ‘out of an abundance of caution’

Following an investigation into possible paper mill activities, the journal Cureus has barred a doctor in Pakistan from publishing more papers “out of an abundance of caution,” Retraction Watch has learned.

The journal investigated Satish Kumar, an internist at Shaheed Mohtarma Benazir Bhutto Medical College in Karachi, after a tipster accused him of selling authorship of scientific papers to scientists who did not participate in the research.

The tipster, who wishes to remain anonymous to avoid backlash from the authors of these papers, sent Cureus WhatsApp messages from a group called “research Match Residency.” There, a user named ”SSS” sent paper titles and offered author slots on manuscripts. Many of the articles were slated for publication in Cureus.

Misspelled cell lines take on new lives — and why that’s bad for the scientific literature

Human cell lines represent key reagents for many research laboratories. Cell lines are often the first models that researchers choose for experiments such as gene manipulation and drug testing, as they are relatively accessible and inexpensive, particularly compared with mouse and other animal models.

However, cell lines also are prone to contamination by other faster growing cell lines. As a result, many human cell lines purported to represent particular tumor types have been found by genetic testing to be contaminated by other cancer cells. This potential for confusion poses a serious problem for researchers who want to study a particular cancer type but end up using cells from an unrelated disease.

Our team studies wrongly identified nucleotide sequence reagents in cancer research, such as PCR primers and gene knockdown reagents. Recently in the context of an undergraduate student project, we decided to also check the identities of cell lines in a small group of papers on the human gene miR-145, which codes for a microRNA. We found wrongly identified nucleotide sequences and cell lines in numerous articles about miR-145, but also what appeared to be five misspelled identifiers of contaminated cell lines.

Weekend reads: Citation cartels; a history of scientific integrity; another Nobelist retracts a paper

Would you consider a donation to support Weekend Reads, and our daily work?

The week at Retraction Watch featured:

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

How a sleuth’s email turned a correction into a retraction

On Sept. 2, 2021, a professor at the University of Iowa, in Iowa City, emailed a biochemistry journal asking to correct a paper she had published the previous year. An experiment had “unintentionally” been omitted from a figure, Isabella Grumbach explained, and a comparison of experimental groups contained “a minor error in the degree of statistical significance.” A correction ensued.

But the problems with the article, “Inhibition of CaMKII in mitochondria preserves endothelial barrier function after irradiation,” appear to have been more deep-rooted than the email suggested. An anonymous commenter on PubPeer had first raised concerns about the article, which had appeared in Free Radical Biology and Medicine (FRBM), in July 2021, more than a year after it was published. The commenter claimed error bars between two figures were vastly different, even though they were meant to be related data points.

Iran COVID-vaccine paper with ‘serious flaws’ retracted

Following criticism from scientists around the world, a virology journal has retracted a paper describing the first test in humans of an Iran-made vaccine against COVID-19.

Iran licensed the home-grown Noora vaccine for emergency use in 2022 and has reportedly administered millions of doses to its citizens. The country’s health authorities say the shot is 94% effective.

The now-retracted paper, published in 2022 in the Journal of Medical Virology, was the only report on the clinical development of the vaccine to have appeared in an international journal. The article has been cited 10 times, according to Clarivate’s Web of Science.

Editorial board members resign from obstetrics journal to protest handling of allegations

A group of 10 members of the editorial board of BMC Pregnancy and Childbirth have resigned to protest the journal’s failure to respond to allegations of data fabrication.

Last week, in an email obtained by Retraction Watch, the editors wrote to Tovah Aronin, the managing editor of the journal, regarding “concerns about the publication of fraudulent research in BMC Pregnancy and Childbirth and BMC Women’s Health in 2023.”

The allegations about two papers had been sent to the journal on Jan. 29, 2024, by Ben Mol, an obstetrician-gynecologist who has earned a reputation as a sleuth for his efforts to clean up the literature in the field:

Cancer paper earns expression of concern nearly two years after investigation report is revealed

A Springer Nature journal has issued an expression of concern for a 16-year-old paper by Carlo Croce, the cancer researcher – and noted art collector – at The Ohio State University three years after the publication had received a correction for problematic images and roughly 20 months after the news division at Nature reported on a pair of institutional investigations into problems with Croce’s work.

As we and others have reported, those investigations concluded Croce had not committed misconduct but had overlooked the misdeeds of others in his lab.

Here’s the notice for the paper, “MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer,” which Oncogene published in 2008:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: